ENTRY       D10751            Mixture   Drug
NAME        Naltrexone and bupropion;
            Contrave (TN)
PRODUCT     CONTRAVE (Nalpropion Pharmaceuticals LLC)
COMPONENT   (Naltrexone hydrochloride [DR:D02095] | Naltrexone [DR:D05113] | Methylnaltrexone bromide [DR:D06618]), (Bupropion hydrochloride [DR:D00817] | Bupropion [DR:D07591] | Bupropion hydrobromide [DR:D07938])
REMARK      ATC code: A08AA62
            Product: D10751<US>
EFFICACY    Antiobesity
COMMENT     Treatment of obesity
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
               A08A ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
                A08AA Centrally acting antiobesity products
                 A08AA62 Bupropion and naltrexone
                  D10751  Naltrexone and bupropion &lt;US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10751
DBLINKS     PubChem: 273220347
///
